Dual MAPK/VEGF inhibition for KRAS-mutated brain arteriovenous malformations
Ryan M. Naylor(Mayo Clinic), Ram Kadirvel(Mayo Clinic), Anna Haugen(Mayo Clinic), Yasuhito Ueki(Mayo Clinic), Fatmah R. Alsereidi(Mayo Clinic)
Cited by 0
Related Papers
Dapagliflozin mitigates cellular stress and inflammation through PI3K/AKT pathway modulation in cardiomyocytes, aortic endothelial cells, and stem cell-derived β cells
|Cardiovascular Diabetology|2024|50
Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement
|Current Problems in Cardiology|2024|40
Nuclear pore protein NUP88 activates anaphase-promoting complex to promote aneuploidy
|Journal of Clinical Investigation|2016|39
CARDIO-PROTECTIVE ROLE OF ROSMARINIC ACID ON ISOPRENALINE INDUCED CARDIAC DYSFUNCTION
|Atherosclerosis|2024|0